Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
Crossref DOI link: https://doi.org/10.1007/s40264-021-01130-7
Published Online: 2021-12-23
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Day, John W.
Mendell, Jerry R.
Mercuri, Eugenio
Finkel, Richard S.
Strauss, Kevin A.
Kleyn, Aaron
Tauscher-Wisniewski, Sitra
Tukov, Francis Fonyuy
Reyna, Sandra P.
Chand, Deepa H.
Text and Data Mining valid from 2021-12-23
Version of Record valid from 2021-12-23
Article History
First Online: 23 December 2021